10.9 C
London
Sunday, February 23, 2025
HomeMarketsEurope Markets

Europe Markets

spot_img

Remsima | European Medicines Agency (EMA)

OverviewRemsima is an anti-inflammatory medicine that contains the active substance infliximab. It is usually used when other medicines or treatments have failed, in...

Sunosi | European Medicines Agency (EMA)

OverviewSunosi is a medicine used to improve wakefulness and reduce excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnoea.Narcolepsy is a...

Yellox | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR) for Yellox. It explains how the Agency assessed the medicine to recommend...

Posaconazole AHCL | European Medicines Agency (EMA)

OverviewPosaconazole AHCL is an antifungal medicine used to treat adults with the following fungal diseases, when treatments with other antifungal medicines (amphotericin B,...

Levitra | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR) for Levitra. It explains how the Committee for Medicinal Products for Human...

Potactasol | European Medicines Agency (EMA)

OverviewThis is a summary of the European public assessment report (EPAR) for Potactasol. It explains how the Committee for Medicinal Products for Human...

Voriconazole Hikma (previously Voriconazole Hospira)

OverviewThis is a summary of the European public assessment report (EPAR) for Voriconazole Hikma. It explains how the Agency assessed the medicine to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img